Lung Carcinoma — Trials

Lung Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

7,788 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,127
Recruiting: 1,127
Ph III recruiting: 164
Growth YoY: +0.6%
Industry share: 43%
Top sponsor: National Cancer Institute (NCI)
Termination share: 38.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,177)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04147494	Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues	active not recruiting	Early Phase 1	29	Jonsson Comprehensive Cancer CenterOTHER	1	Aug 21, 2026	clinicaltrials
NCT04906746	Ruxolitinib for Cancer Cachexia	active not recruiting	Early Phase 1	10	Tu DanOTHER	1	Jul 7, 2026	clinicaltrials